Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vericel Corporation
(NQ:
VCEL
)
49.94
+0.65 (+1.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Vericel Corporation
< Previous
1
2
Next >
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
Today 7:45 EDT
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
August 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
August 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
July 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
July 18, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
June 11, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
May 22, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
May 08, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
February 29, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
February 27, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
February 15, 2024
From
Vericel Corporation
Via
GlobeNewswire
5 medical stocks growing earnings by triple digits
February 06, 2024
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning
Via
MarketBeat
Topics
Economy
Exposures
Economy
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 05, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session
January 23, 2024
Via
Investor Brand Network
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
January 09, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
January 03, 2024
From
Vericel Corporation
Via
GlobeNewswire
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
November 08, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Stephens Annual Investment Conference
November 07, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
October 25, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
September 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
September 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
August 02, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023
July 20, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session
May 23, 2023
Via
Investor Brand Network
Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
May 10, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023
April 26, 2023
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023
February 28, 2023
From
Vericel Corporation
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.